U.S. endocrine-focused pharmaceutical development and commercialization firm Crinetics Pharmaceuticals has confirmed an ongoing investigation into a cybersecurity incident claimed by the LockBit ransomware operation to have resulted in data compromise, according to The Record, a news site by cybersecurity firm Recorded Future.

Source: SC Magazine